68GaGa-NODAGA40Lys-Exendin-4 (68Ga-Ex-4) is a new PET radiopharmaceutical targeting GLP-1-R that showed great specificity and sensitivity in the topographic diagnosis of benign insulinoma. We herein report the development of a new method for 68Ga-Ex-4 radiolabeling in sodium acetate buffer, automated on the miniAllinOne synthesizer. Key parameters were reaction volume, due to low amount of peptide, and pH. At a reaction volume of 2.65 mL and pH 2.9, the reaction yielded 80% of 68Ga-Ex-4. The use of polysorbate and cooling of the solution allows to decrease the adsorption on the reaction vial (from 29 to 2% of total activity remaining on the vial). 68Ga-Ex-4 is purified on a HLB cartridge. Final product was obtained within 40 min, with a mean radiochemical purity of 97% and a radiochemical yield of 67%. We have successfully developed a new radiolabeling method for 68GaGa-NODAGA-40LysExendin-4, automated on a miniAllinOne synthesizer and using sodium acetate buffer, suitable for clinical application.
Ragot et al. (Mon,) studied this question.